PBTK modeling of potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico-in vitro based risk assessments

被引：0
|
作者：
Fabian, E. [1 ]
Haase, C. [1 ]
Ramirez, T. [1 ]
Gomes, C. [1 ]
Birk, B. [1 ]
van Ravenzwaay, B. [1 ]
Landsiedel, R. [1 ]
机构：
[1] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2017年 / 390卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P265
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [21] Fish Physiologically Based Toxicokinetic Modeling Approach for In Vitro-In Vivo and Cross-Species Extrapolation of Endocrine-Disrupting Chemicals in Risk Assessment
    Xie, Ruili
    Xu, Yiping
    Ma, Mei
    Wang, Zijian
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2024, 58 (08) : 3677 - 3689
  • [22] The importance of protein binding for the in vitro-in vivo extrapolation (IVIVE)-example of ibuprofen, a highly protein-bound substance
    Mielke, H.
    Di Consiglio, E.
    Kreutz, R.
    Partosch, F.
    Testai, E.
    Gundert-Remy, U.
    ARCHIVES OF TOXICOLOGY, 2017, 91 (04) : 1663 - 1670
  • [23] Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: Case example diclofenac
    Kambayashi, Atsushi
    Blume, Henning
    Dressman, Jennifer
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 1337 - 1347
  • [24] Overview of in vitro-in vivo extrapolation approaches for the risk assessment of nanomaterial toxicity
    Azizah, Rahmasari Nur
    Verheyen, Geert R.
    Shkedy, Ziv
    Van Miert, Sabine
    NANOIMPACT, 2024, 35
  • [25] Special Issue: Invited Reviews on the New Organic Cation (OCTN) and Anion (OATP) Tranporters and In Vitro-In Vivo Extrapolation (IVIVE)
    Pang, K. Sandy
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (01) : 1 - 1
  • [26] Developmental neurotoxicity evaluation of acrylamide based on in vitro to in vivo extrapolation by pregnancy PBTK modelling
    Johansson, Ylva
    Awoga, Roseline Ayowumi
    Forsby, Anna
    TOXICOLOGY, 2024, 509
  • [27] Using In Vitro to In Vivo Extrapolation (IVIVE) to Apply Genetic Toxicity Data to Regulatory Risk Assessment
    Beal, Mark A.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 : 23 - 23
  • [28] Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways
    Benet, Leslie Z.
    Sodhi, Jasleen K.
    AAPS JOURNAL, 2020, 22 (05):
  • [29] In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications
    Cho, Hyun-Jong
    Kim, Ji-Eon
    Kim, Dae-Duk
    Yoon, In-Soo
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (08) : 989 - 998
  • [30] Application of adverse outcome pathways and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for risk assessment based on in vitro data
    Mally, A.
    Birk, B.
    Di Fiore, S.
    Ellinger, B.
    Jarzina, S.
    Reiser, P.
    Taverne, F.
    Kramer, N.
    TOXICOLOGY LETTERS, 2019, 314 : S140 - S140
12345